GlassScriptPhysician profile
Gary M Rodberg
NPI 1255437117
$4,904.25
in general payments reported to CMS, 2019-2025
31 companies · $16.24 in 2025
The $16.24 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,218 · 2020: $853 · 2021: $921 · 2022: $1,690 · 2023: $172 · 2024: $34.72 · 2025: $16.24.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $190 · Education: $32.48.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $190.31 |
| Education | $32.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $755.13 | 2019-2023 | Trelegy Ellipta |
| Ethicon INC. | $674.23 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $622.00 | 2019-2022 | |
| Electromed, INC. | $354.66 | 2019-2024 | Smartvest |
| Astrazeneca Pharmaceuticals LP | $345.43 | 2019-2023 | Tezspire |
| Regeneron Healthcare Solutions, INC. | $312.50 | 2019-2023 | Dupixent |
| Actelion Pharmaceuticals US, INC. | $274.58 | 2019-2022 | |
| Vero Biotech INC. | $179.45 | 2020 | |
| Philips North America LLC | $160.36 | 2019-2022 | |
| Inspire Medical Systems, INC. | $157.64 | 2021 | |
| Grifols USA, LLC | $134.65 | 2019-2023 | Prolastin-C Liquid |
| Sunovion Pharmaceuticals INC. | $110.46 | 2019-2020 | |
| Mylan Specialty L.P. | $109.85 | 2019-2022 | |
| United Therapeutics Corporation | $99.66 | 2019-2023 | Tyvaso |
| Genzyme Corporation | $95.57 | 2019-2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Resmed Corp | $77.56 | 2020-2022 | |
| Baxter Healthcare | $71.28 | 2022-2023 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Merck Sharp & Dohme LLC | $63.38 | 2019-2020 | |
| Jazz Pharmaceuticals INC. | $36.53 | 2020-2021 | |
| Pfizer INC. | $35.72 | 2021-2022 | |
| Insmed, INC. | $32.48 | 2024-2025 | Arikayce |
| Genentech USA, INC. | $27.00 | 2019 | |
| Olympus America INC. | $26.10 | 2021-2022 | |
| Shire North American Group INC | $25.66 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $24.02 | 2022 | |
| Paratek Pharmaceuticals, INC. | $20.95 | 2021 | |
| Circassia INC. | $19.97 | 2019 | |
| Veran Medical Technologies, INC. | $16.99 | 2019 | |
| Advanced Respiratory, INC | $16.52 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.29 | 2020 | |
| Fisher & Paykel Healthcare INC | $10.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Rodberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.